Q32 Bio Inc. (QTTB) Form 424B5 — Jul 15, 2026
Q32 Bio Inc. is raising approximately $200 million in gross proceeds through a public offering of 6.0 million shares of common stock and 4.9 million pre-funded warrants priced at $18.25 per share. This offering price represents a significant premium of over 60% to the last reported sale price of $11.21 on July 10, 2026. The company intends to use the net proceeds of roughly $188 million for working capital and to fund the clinical development and commercialization efforts for its lead product candidate, bempikibart.
Key figures
- Gross Proceeds
- 199,999,523.10
- Offering Price
- 18.25
- Shares Offered
- 6027399
- Debt Paid Off
- 6,800,000
- Net Proceeds
- 187,999,522.12
- Greenshoe Shares
- 1643835
- Dilution Per Share
- 8.13
- Pre Funded Warrant Price
- 18.2499
- Prior Market Close Price
- 11.21
- Pre Funded Warrants Offered
- 4931506
Price after filing
Close on the filing date to close N calendar days later (from $15.70). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.